Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Alopecia areata involves unique activation of certain immune cells.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Human thymus has stem cells that can self-renew and maintain their identity.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

γδ T cells adapt uniquely to different tissues in mice.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Targeting CD169+ skin macrophages may help treat psoriasis.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Skin cells control immune cell placement, helping the skin respond better to challenges.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

TLR4 is important in aging-related diseases and could be a new treatment target.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.